Literature DB >> 10953268

Implantable dual-chamber cardioverter-defibrillator-pacemaker.

D Pfeiffer1, M Mende, A Hagendorff.   

Abstract

The fifth generation of implantable cardioverter-defibrillators offer enhanced modes of detection of atrial and ventricular arrhythmias, antitachycardia pacing and shocks, multiprogrammability, intracardiac electrogram storage, and all functions of antibradycardia dual-chamber pacing including rate responsiveness and mode switching. There is no consensus on the indications for dual-chamber pacemaker defibrillator systems. This review focuses on the four major options of newer devices that might benefit patients: 1) permanent dual-chamber pacing in ischemic coronary disease patients, 2) detection and management of atrial fibrillation or other atrial tachyarrhythmias, 3) some newer indications for pacing, and 4) the suppression of inappropriate interventions. On the basis of published data, newer indications for the dual-chamber systems, advantages and limitations, and future perspectives are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10953268     DOI: 10.1007/s11886-000-0090-6

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  57 in total

1.  Indications for implantation of a dual-chamber pacemaker combined with an implantable cardioverter-defibrillator.

Authors:  S L Higgins; S K Williams; J P Pak; D B Meyer
Journal:  Am J Cardiol       Date:  1998-06-01       Impact factor: 2.778

2.  Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias.

Authors:  W Jung; B Lüderitz
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

3.  New ICD-technologies: first clinical experience with dual-chamber sensing for differentiation of supraventricular tachyarrhythmias.

Authors:  S Osswald; T A Cron; L Sterns; E Alt; L Stotts; M Coenen
Journal:  Pacing Clin Electrophysiol       Date:  1998-01       Impact factor: 1.976

4.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

5.  The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators.

Authors:  P J Best; D L Hayes; M S Stanton
Journal:  Pacing Clin Electrophysiol       Date:  1999-01       Impact factor: 1.976

6.  Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.

Authors:  C D Swerdlow; P S Chen; R M Kass; J R Allard; C T Peter
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

7.  Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).

Authors:  J Siebels; K H Kuck
Journal:  Am Heart J       Date:  1994-04       Impact factor: 4.749

8.  Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.

Authors:  W Grimm; B F Flores; F E Marchlinski
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

9.  Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers.

Authors:  R Brooks; H Garan; B A McGovern; J N Ruskin
Journal:  Am Heart J       Date:  1995-01       Impact factor: 4.749

10.  Prospective evaluation of new and old criteria to discriminate between supraventricular and ventricular tachycardia in implantable defibrillators.

Authors:  H S Barold; K H Newby; G Tomassoni; M Kearney; J Brandon; A Natale
Journal:  Pacing Clin Electrophysiol       Date:  1998-07       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.